Evidence map›Paper›PMID 38093751›Full record

ArticleFrontiers in neurology2023

Clinical Functional Seizure Score (CFSS): a simple algorithm for clinicians to suspect functional seizures.

Mohammad Dashtkoohi, Sakineh Ranji-Bourachaloo, Rozhina Pouremamali, Mohadese Dashtkoohi, Raha Zamani, Aysan Moeinafshar, Arshia Shizarpour, Shirin Shakiba, Mohammadali Babaee, Abbas Tafakhori

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mohammad DashtkoohiStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Sakineh Ranji-BourachalooIranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Rozhina PouremamaliStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Mohadese DashtkoohiStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Raha ZamaniStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Aysan MoeinafsharStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Arshia ShizarpourStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Shirin ShakibaIranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadali BabaeeIranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abbas TafakhoriIranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Distinguishing functional seizures (FS) from epileptic seizures (ES) poses a challenge due to similar clinical manifestations. The creation of a clinical scoring system that assists in accurately diagnosing patients with FS would be a valuable contribution to medical practice. This score has the potential to enhance clinical decision-making and facilitate prompt diagnosis of patients with FS. Methods: Participants who met the inclusion criteria were randomly divided into three distinct groups: training, validation, and test cohorts. Demographic and semiological variables were analyzed in the training cohort by univariate analyses. Variables that showed a significant difference between FS and ES were then further scrutinized in two multivariate logistic regression models. The CFSS was developed based on the odds ratio of the discriminating variables. Using the validation group, the optimal cutoff value was determined based on the AUC, and then the CFSS was evaluated in the test cohort to assess its performance. Results: The developed score yielded an AUC of 0.78 in the validation cohort, and a cutoff point of 6 was established with a focus on maximizing sensitivity without significantly compromising specificity. The score was then applied in the test cohort, where it achieved a sensitivity of 86.96% and a specificity of 73.81%. Conclusion: We have developed a new tool that shows promising results in identifying patients suspicious of FS. With further analysis through prospective studies, this innovative, simple tool can be integrated into the diagnostic process of FS.

Indexed as

diagnosisepilepsyneurobehavioral manifestationspsychogenic nonepileptic seizuresseizures

Identifiers

PMID38093751
PMCPMC10716468
OpenAlexW4389150051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.